rxdx acquisition：Merck Completes Acquisition of Prometheus Biosciences
Merck Completes Acquisition of Prometheus Biosciences
2023年6月16日—(“Prometheus”)(NASDAQ:RXDX)acquisition.Prometheusisnowawholly-ownedsubsidiaryofMerckandthecommonstockofPrometheuswillno ...。其他文章還包含有：「MerckAcquiresPrometheusBiosciencesfor$10.8Billion」、「MerckStrengthensImmunologyPipelinewithAcquisitionof...」、「MercktobuyPrometheusBiosciencesforabout$11billion」、「MSDCompletesAcquisitionofPrometheusBiosciences」
查看更多 離開網站
Merck Acquires Prometheus Biosciences for $10.8 Billion
https://www.investopedia.com
Shares of Prometheus Biosciences (RXDX) jumped on Monday after the maker of intestinal inflammatory disease treatments said it will be ...
Merck Strengthens Immunology Pipeline with Acquisition of ...
https://www.merck.com
(“Prometheus”) (Nasdaq: RXDX) today announced that the companies have entered into a definitive agreement under which Merck, through a ...
Merck to buy Prometheus Biosciences for about $11 billion
https://www.reuters.com
April 16 (Reuters) - Merck & Co (MRK.N) said on Sunday it will buy Prometheus Biosciences Inc (RXDX.O) for about $10.8 billion, ...
MSD Completes Acquisition of Prometheus Biosciences
https://www.msd.com
(“Prometheus”) (NASDAQ: RXDX) acquisition. Prometheus is now a wholly-owned subsidiary of MSD and the common stock of Prometheus will no ...